Werbung
BioXcel Therapeutics Aktie Analyse
06.04.18 | BioXcel Therapeutics Outperform | BMO Capital Markets | |
02.04.18 | BioXcel Therapeutics overweight | Barclays Capital |
Werbung
Werbung